Western Kentucky University

TopSCHOLAR®
Masters Theses & Specialist Projects

Graduate School

Spring 2018

Correlation Between Female Athlete Screening
Tool (FAST) Scores and Biomarkers to Identify
Female Athlete Triad Among Collegiate Athletes
and to Evaluate the Validity of the Instrument
Lindsey Elise Hinken
Western Kentucky University, lindsey.hinken301@topper.wku.edu

Follow this and additional works at: https://digitalcommons.wku.edu/theses
Part of the Exercise Science Commons, Nutrition Commons, and the Psychology Commons
Recommended Citation
Hinken, Lindsey Elise, "Correlation Between Female Athlete Screening Tool (FAST) Scores and Biomarkers to Identify Female
Athlete Triad Among Collegiate Athletes and to Evaluate the Validity of the Instrument" (2018). Masters Theses & Specialist Projects.
Paper 2331.
https://digitalcommons.wku.edu/theses/2331

This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by
an authorized administrator of TopSCHOLAR®. For more information, please contact topscholar@wku.edu.

CORRELATION BETWEEN FEMALE ATHLETE SCREENING TOOL (FAST)
SCORES AND BIOMARKERS TO IDENTIFY FEMALE ATHLETE TRIAD
AMONG COLLEGIATE ATHLETES AND TO EVALUATE THE VALIDITY OF
THE INSTRUMENT

A Thesis
Presented to
The Faculty of the Department of Psychology
Western Kentucky University
Bowling Green, Kentucky

In Partial Fulfillment
Of the Requirements for the Degree
Master of Arts

By
Lindsey Elise Hinken
May 2018

ACKNOWLEDGMENTS
Primarily, I would like to thank Dr. Rick Grieve, Dr. Lee Winchester, and Dr. Ray
VanWye for their guidance in the completion of this research. I would like to thank my
fiancé, Samuel Tegge, for his assistance with data collection and analysis. I would also
like to thank Samuel, my classmates, and my family for their continued support and
encouragement throughout my education. Lastly, I would like to acknowledge Western
Kentucky University’s Exercise Science department for allowing me to use their lab space
and equipment

iii

CONTENTS
Introduction................…………………………………………………………..................1
Literature Review................…………………………………………………….................6
Methods……………………………………………………………..................................13
Results..........................……………………………………...........…...............................18
Discussion..........................................................................................................................23
References……………………………………………………………………..…............28
Appendix A: Demographics……………………………………………………...............32
Appendix B: Menstrual Status Questionnaire…………………………………….............34
Appendix C: Female Athlete Screening Tool……………………………………….........35
Appendix D: Blood Sampling Protocol……………………………………………..........36
Appendix E: ELISA Protocol…………………………………………………….............37
Appendix F: Informed Consent..........................................................................................39
Appendix G: Debriefing.....................................................................................................41

iv

LIST OF FIGURES
Figure 1. Prealbumin levels of varsity versus recreational athletes……......…………….21
Figure 2. CTx levels of varsity versus recreational athletes.………………………….....22

v

CORRELATION BETWEEN FEMALE ATHLETE SCREENING TOOL (FAST)
SCORES AND BIOMARKERS TO IDENTIFY FEMALE ATHLETE TRIAD AMONG
COLLEGIATE ATHLETES AND TO EVALUATE THE VALIDITY OF THE
INSTRUMENT
Lindsey Hinken

May 2018

41 Pages

Directed by: Dr. Frederick Grieve, Dr. Lee Winchester, and Dr. Ray VanWye
Department of Psychology

Western Kentucky University

The purpose of this study was to determine if the Female Athlete Screening Tool
(FAST) is a valid indicator of the three physical components of Female Athlete Triad
(FAT), malnutrition, amenorrhea, and low bone mineral density, and if administration of
the FAST can be used as a time- and cost-effective way to identify FAT. Participants
completed the FAST, the Menstrual Status Questionnaire, and had a blood sample drawn.
Interpretation of the total FAST score placed participants in one of three conditions:
normal, subclinical disordered eating, or clinical eating disorder. The presence of the
three biomarkers of FAT was determined by participants’ responses on the Menstrual
Status Questionnaire and protein analyses of their blood samples, in which plasma
Prealbumin and CTx levels were tested. Results indicated that there were not significant
differences between total FAST scores of participants in each of the groups for any of the
three biomarkers (i.e., low versus normal Prealbumin levels; amenorrhea versus normal
menstruation; high versus normal CTx levels). More research is needed before it can be
determined if the FAST is an appropriate diagnostic tool for FAT. An overwhelming
majority of the sample (79.5%) received total FAST scores that fell in the subclinical
disordered eating or clinical eating disorder ranges, which supports previous findings that
female athletes are at a high risk of developing disordered eating habits or eating
disorders due to their unique characteristics and lifestyles.

vi

Introduction
A dangerous health condition is on the rise among today’s female athletes,
especially adolescents and young adults who participate in endurance and aestheticallyjudged sports. Female Athlete Triad (FAT) is characterized by the presence of three
independent, yet intricately related, conditions: malnutrition, amenorrhea, and low bone
mineral density (BMD; Yeager, Agostini, Nattiv, & Drinkwater, 1993). The concurrence
of these three symptoms leads to severe consequences for athletes’ short- and long-term
health (Knapp, Aerni, & Anderson, 2014). It is estimated that up to 16% of female
athletes experience all three components of FAT, and that 60% of athletes in particular
sports are affected by two of the three components of FAT (Barrack, Ackerman, &
Gibbs, 2013). Collegiate endurance athletes may be among the most susceptible to
developing FAT (Bonci et al., 2008; Knapp et al., 2014; Sherman & Thompson, n.d.).
Due to its prevalence and severe consequences, FAT deserves substantial research
attention.
Past Findings and Future Directions of FAT Research
Previous literature has detailed the three components of FAT, as well as
investigated risk factors and causes, prevalence, prevention, long term health
consequences, and treatments of FAT (International Olympic Committee Medical
Commission Working Group Women in Sport [IOC], 2005). The first component of
FAT is malnutrition due to disordered eating. Athletes’ disordered eating can be
unintentional (i.e., athletes mistakenly underestimate their caloric needs) or intentional
(i.e., athletes engage in dieting or have clinical eating disorders; Sherman & Thompson,
n.d.). Disordered eating may arise from athletes’ intention to perform better in their
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sport; however, it does not usually occur as a direct result of sport participation, and
affected athletes would most likely practice disordered eating under other circumstances
(Sherman & Thompson, n.d.). Disordered eating is often considered the precipitating
factor of FAT, as malnutrition in young females can lead to amenorrhea, which then
causes low BMD (Sherman & Thompson, n.d.)
The second component of FAT, amenorrhea, is the cessation of menstruation for
at least three consecutive months. Amenorrhea can occur as a result of various
circumstances, including pregnancy, abnormal hormone levels, tumors of the pituitary
gland, and steroid use (Sherman & Thompson, n.d.). In the case of FAT, athletes
experience amenorrhea due to low energy availability, as a result of disordered eating.
Chronic energy deficiency, caused by inadequate dietary intake, excessive exercise, or
both, interferes with hormones that are involved in reproductive development and
functioning (IOC, 2005).
Low BMD, the third FAT component, is a result of the two preceding factors.
Bone minerals, such as calcium and phosphate, deteriorate quickly in the absence of
adequate nutrition and estrogen, which are both essential for healthy bone growth
(Sherman & Thompson, n.d.). Low BMD occurs when the rate of bone growth is
exceeded by that of bone resorption. It is particularly problematic when FAT affects
pubescent athletes, during the time when they should be accumulating peak bone mass
(IOC, 2005). Bone mass degenerates quickly in amenorrheic athletes; low BMD
increases the risk of fractures, and is potentially irreversible (Yeager et al., 1993).
A variety of risk factors contribute to the development of FAT, including dieting,
social pressure, belief that low body weight contributes to athletic success, and desire to
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gain competitive advantage (Kransdorf, Vegunta, & Files, 2013; Thompson, 2007). Low
energy balance due to inadequate caloric intake, amenorrhea, and low BMD have
physiological repercussions that impact current athletic performance and lifelong health
(Marquez & Molinero, 2013; Zeigler, n.d.). Athletes with FAT experience muscle loss,
fatigue, stress fractures, anemia, depression, and infertility (IOC, 2005). Treatment is
most successful when implemented by a team of experts, and when intervention occurs
early (Lassiter & Watt, 2007; Zeigler, n.d.). However, treatment is difficult; initial
prevention of FAT, by means of screenings and pre-participation exams, is the best
approach. Nonetheless, research indicates that few athletic institutions implement such
assessments. The insufficient use of appropriate prevention and screening techniques
highlights the importance of the present topic, and this study took steps to investigate
and fill gaps in the current body of knowledge.
FAT Identification Dilemmas
One issue of particular interest is the ability to recognize athletes who are at high
risk of developing FAT. Self-report questionnaires are commonly employed as screening
tools to identify those at risk of developing eating disorders. However, measures of this
sort typically do not consider the unique characteristics of the female athlete population,
who may be predisposed to pathological eating attitudes and behaviors and driven by
motivation for athletic success (McNulty, Adams, Anderson, & Affenito, 2001). It can be
difficult to diagnose eating disorders in athletes because many signs of such pathology
can be explained by characteristics of “good athletes,” such as self-discipline, persistence,
dedication to training, and high expectations (Kransdorf et al., 2013; Thompson, 2007).
McNulty and colleagues (2001) developed a screening tool specifically to identify eating
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disorders in female athletes. They demonstrated the discriminant validity of the Female
Athlete Screening Tool (FAST) by showing that it accurately differentiates between
athletes and non-athletes with and without eating disorders (McNulty et al., 2001).
However, to date, there is no evidence that the FAST is a valid indicator of the presence
of the three components of FAT.
A Proposition for More Accurate FAT Screening
Accurate detection of FAT using biomarkers is time consuming and expensive. It
is not realistic to implement such intensive screening for all athletes. Administering the
FAST to athletes could be an ideal solution to this dilemma. In the present study, the
manifestation of the symptoms of FAT was compared to outcomes of the FAST. If the
FAT components occurred in correlation with above-threshold FAST scores, then there
would be evidence that the FAST is an accurate tool for predicting FAT among athletes.
The FAST takes a relatively short time to complete and interpret, and it is available at no
cost to the public. This protocol would facilitate the FAT screening process. In turn, more
efficient detection of FAT would allow early intervention, which is critical in the
recovery process. This study carries significant implications for individual athletes and
sports institutions at large; perhaps the validation of such a screening tool would lead to
more frequent utilization of FAT assessments and pre-participation exams.
In summary, the purpose of this study was to investigate the co-occurrence of
FAT physical symptoms and above-threshold scores on the FAST. The independent
variables were the three biomarkers of FAT, including malnutrition, which was measured
via plasma levels of Prealbumin; amenorrhea, which was measured via self-reported
menstrual history; and low BMD, which was measured via plasma levels of collagen C-
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terminal telopeptide (CTx). The dependent variable was the value of participants’ FAST
scores; a score of 79 or higher is considered above-threshold and suggests the occurrence
of disordered eating patterns. Data, including FAST scores and physiological conditions,
were collected from 40 athletic females from one National Collegiate Athletic
Association (NCAA) Division I university in the Southcentral United States to determine
the FAST’s efficacy in accurately indicating the presence of FAT in female athletes.
The goal of this research was to determine if the FAST is a valid indicator of
malnutrition, amenorrhea, and low BMD, which are key, and often “silent,” symptoms of
FAT. The researcher hypothesized that FAST scores would positively correlate with the
three components of FAT. It was postulated that abnormalities in the three biomarkers
under study (plasma Prealbumin and CTx levels and menstrual history) would predict
higher FAST scores.
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Literature Review
Female Athlete Triad (FAT) is a complicated condition that arises from
interactions between biological, psychological, and social factors (Bonci et al., 2008);
therefore, relevant research has been conducted in a variety of academic domains,
including Psychology, Nutrition, and Exercise Science, among others. FAT is
characterized by the presence of three physiological conditions: low energy availability,
amenorrhea, and low bone mineral density (BMD). Low energy availability is often the
triggering factor, which consequently leads to amenorrhea, and finally low BMD
(Sherman & Thompson, n.d.). FAT is an important topic to explore because it affects
many young female athletes and has the potential to cause dramatic, and sometimes
irreversible, long-term health consequences.
Previous Research
Preceding literature reveals that the components of FAT are more rampant among
athletes than non-athletes, particularly athletes who are involved in thin-build, aesthetic,
or endurance sports (Barrack et al., 2013; Thompson, 2007). The true prevalence of FAT
is unknown, but it is estimated that disordered eating affects up to 35.4% of athletes,
menstrual dysfunction affects up to 54% of athletes, and low BMD affects up to 22% of
athletes (Barrack et al., 2013). The occurrence of amenorrhea during adolescence may
have implications for future bone and reproductive health. Lack of normal menstruation
may prevent females from reaching peak bone mass, which can cause increased
susceptibility to bone injuries, osteopenia, or osteoporosis (IOC, 2005). Further, even
after the resumption of normal menstruation, bone mass may not fully recover (Barrack et
al., 2013; Ziegler, n.d.). In addition, a persistent absence of progesterone, due to
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amenorrhea, may cause females to experience infertility in the future (IOC, 2005). The
significant number of female athletes affected, and the severity of its long-term effects,
demonstrate the importance of continuing to study FAT.
Each of the FAT variables exist on a continuum of severity that ranges from
health to disease (Nattiv, Loucks, Manore, Sanborn, Sundgot-Borgen, & Warren, 2007).
Low energy availability may be unintentional, deliberate, or pathological (Nattiv et al.,
2007). Intentional low energy intake can be a result of abnormal eating behaviors,
subclinical disordered eating, or clinical eating disorders, such as Anorexia Nervosa,
Bulimia Nervosa, or eating disorders not otherwise specified (EDNOS; IOC, 2005).
Prolonged low energy availability can lead to a state of malnutrition, during which
physiological functions that are needed for development and health maintenance, such as
menstruation and bone growth, are suppressed (IOC, 2005; Nattiv et al., 2007). Various
physiological conditions can be determined by examining levels of particular proteins in
the blood. Specifically, Prealbumin, has been identified as the earliest bio-indicator of
nutritional status, and is considered the primary marker for malnutrition (Beck &
Rosenthal, 2002). Low levels of Prealbumin, a plasma protein produced by the liver, are
indicative of compromised visceral protein production, which occurs in states of nutrient
deficiency (Smith, 2017). Prealbumin levels <15 mg/dL fall below the “normal” range
and may indicate an increased risk of poor nutritional status (Beck & Rosenthal, 2002).
The existing literature suggests that the second component of FAT, amenorrhea,
occurs when insufficient energy availability disrupts the secretion of luteinizing hormone
(LH), which is a critical component in the process of normal follicular development
(IOC, 2005). In contrast to previous beliefs, LH levels, and, consequently, menstrual
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cycles are not disrupted by exercise alone; rather, abnormal menstruation is a result of the
negative energy balance that occurs when there is not an increase in nutritional intake to
compensate for exercise energy expenditure (IOC, 2005). Like low energy availability,
abnormal menstruation also exists on a continuum of severity, which ranges from
irregular menstrual cycles (oligomenorrhea) to persistent absence of cycles for at least
three months (amenorrhea; IOC, 2005).
The third component of FAT, low BMD, is generally seen in postmenopausal
elderly women. However, it is increasingly seen among young female athletes due to low
energy availability and hindered bone development, resulting from inadequate nutrition
and irregular menstrual cycles, which disrupt bone growth and maintenance (IOC, 2005).
Calcium and phosphate, two minerals stored within bones, are essential for developing
and supporting bone strength (“What Causes,” 2016). During nutrition deficits and states
of low energy availability, these minerals are reabsorbed from the bones into the blood;
they are utilized for other functions elsewhere in the body, and, consequently, bone
integrity is compromised (“What Causes,” 2016). Athletes with low BMD are at an
increased risk for fractures and other musculoskeletal injuries (IOC, 2005).
Like the two preceding FAT variables, BMD exists on a continuum. Ageappropriate bone growth and development constitute the healthy end of this range;
osteopenia and osteoporosis, which are bone loss diseases of increasing severity,
respectively, lie at the disease end of this continuum (Nattiv et al., 2007). Osteopenia and
osteoporosis occur as a result of increased bone resorption in the absence of
compensatory bone formation (Mayo Medical Laboratories, n.d.). In the process of bone
resorption, the major component of bone matrix, type I collagen, is degraded into
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molecular fragments by proteases that are secreted by osteoclasts; subsequently, the
carboxyl end of the collagen peptide, CTx, is secreted into the bloodstream
(ClinLabNavigator, 2017; Mayo Medical Laboratories, n.d.). High plasma levels of CTx
function as a biomarker for increased bone resorption (i.e., bone loss), and have been
used to monitor bone breakdown in patients with low BMD (Lab Tests Online, 2017;
Mayo Medical Laboratories, n.d.; Wynn, n.d.). Increased levels of CTx are correlated
with osteopenia and osteoporosis (Mayo Medical Laboratories, n.d.). The reference range
for “normal” plasma CTx concentration among premenopausal women is 25 to
573pg/mL; levels above the expected range have been seen in patients with osteopenia
and osteoporosis (Mayo Medical Laboratories, n.d.).
The importance of detecting FAT has been well-established; however, screening
for this condition can be difficult. Prior research reveals that there is considerable overlap
between characteristics of “good” athletes, those with disordered eating habits, and those
with clinical eating disorders (IOC, 2005; Thompson, 2007). Personality traits of
successful athletes, including high self-motivation, high achievement expectations,
competitiveness, compulsiveness, perfectionism, and over-compliance are risk factors for
eating disorders (IOC, 2005; Macleod, 1998).
The desirability of these traits differs between domains of sport and health.
Coaches often expect and celebrate such characteristics of dedicated, hardworking
athletes, rather than recognize them as potential signs of pathological behavior that are
associated with disordered eating (IOC, 2005). For example, obsessive-compulsive
tendencies and high achievement standards are typically seen among individuals with
eating disorders; these characteristics may also significantly contribute to successful
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athletic performance (IOC, 2005). Additionally, eating disorder patients may engage in
excessive exercise, while dedicated athletes may train longer and harder than their
teammates and competitors (Sherman & Thompson, n.d.). Eating disorder patients often
feel compelled to be perfect; likewise, good athletes strive for excellence in their
performances (Sherman & Thompson, n.d.). Furthermore, eating disorder patients often
go to great lengths to please others and win their approval; similarly, good, “coachable”
athletes are compliant to coaches’ wishes, and are willing to sacrifice their own wellbeing
for that of their team (Sherman & Thompson, n.d.). In addition to these predisposing
personality traits, female athletes with eating disorder pathology also commonly
encounter other contributing factors, including environmental pressures to perform well
and maintain an idealized appearance (Bonci et al., 2008; IOC, 2005; Sherman &
Thompson, n.d.).
Screening for eating disorders among athletes differs greatly from screening the
general population because of these extraneous factors (Knapp et al., 2014).
Consequently, female athlete-specific screening tools have been developed to more
accurately identify eating disorder pathology among this susceptible population. These
specific screening tools are designed to distinguish between female athletes who are
practicing typical athletic training behaviors from those who are at risk of disordered
eating (Knapp et al., 2014). The Athletic Milieu Direct Questionnaire (AMDQ; Nagel,
Black, Leverenz, & Coster, 2000), Brief Eating Disorder in Athletes Questionnaire
(BEDA-Q; Martinsen, Holme, Pensgaard, Torstveit, & Sundgot-Borgen, 2014), and
Female Athlete Screening Tool (FAST; McNulty et al., 2001) are measures that have
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been validated for use with female athletes (Knapp et al., 2014). The FAST is the only
tool that can identify subclinical eating disorders (Knapp et al., 2014).
The FAST is a questionnaire that consists of 33 questions and takes roughly 15
minutes to complete. It has been validated in a population of NCAA Division I and
Division III female collegiate athletes. It has demonstrated the ability to accurately
distinguish among athletes and non-athletes with and without pathological eating
behavior (McNulty et al., 2001). Reliability analysis of this measure revealed that it has a
high internal consistency (Cronbach’s a = .87). Correlation analyses revealed that the
FAST correlates strongly with the Eating Disorder Examination- Questionnaire (EDE-Q;
r = .60) and the Eating Disorder Inventory (EDI; r = .89; McNulty et al., 2001).
Limitations of Previous Research
Existing literature provides evidence that the FAST is a valid screening tool to use
with female athletes to identify eating disorder pathology. However, gaps in the literature
fail to address whether or not the FAST is a valid indicator of the three physiological
components of FAT. No prior research has investigated whether the FAST could be used
as a more time- and cost-effective replacement for thorough physical examination to
detect FAT among female athletes.
The Current Study
The present study sought to fill this void in the existing body of knowledge. The
purpose of this study was to further demonstrate the validity of the FAST by comparing
athletes’ scores on this measure to their objective, physiological manifestations of the
three components of FAT. An additional objective was to provide evidence that the
FAST is a measure capable of accurately identifying disordered eating among varsity and
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recreational female collegiate athletes, which could be used as a more efficient substitute
for extensive physical examinations.
Hypotheses
Based on previous literature, it was predicted that athletes with one or more of the
three physiological manifestations of FAT would produce higher scores on the FAST,
which are indicative of subclinical disordered eating (scores of 79 to 94 points) or a
clinical eating disorder (scores above 94 points), than their healthy peers. The following
hypotheses were evaluated:
1. Participants with insufficient caloric intake (defined by abnormally low levels,
<15.0mg/dL, of plasma Prealbumin, a reliable biomarker of malnutrition) will
score higher on the FAST than their peers.
2. Participants with amenorrhea (defined by the self-reported absence of normal
menstruation for at least three consecutive months) will score higher on the FAST
than their peers.
3. Participants with low bone mineral density (defined by abnormally high levels,
>573pg/mL, of plasma CTx) will score higher on the FAST than their peers.

12

Method
Participants
The presents study’s population of interest consisted of varsity and recreational
female collegiate athletes, who may be at increased risk of developing FAT. A power
analysis was conducted to determine how many participants were needed. Four studies
(Aerni, Knapp, Anderson, & Trojian, 2014; Folscher, Grant, Fletcher, & Janse van
Rensberg, 2015; McNulty et al., 2001; Quatromoni, 2008) were assessed. The studies
included 10 comparisons that yielded effect sizes. The mean effect size was d = 2.75.
With this effect size, having 20 participants per group yields a power of > .99, which
means there is >99% chance of detecting a true difference if it exists.
This study was conducted at an NCAA Division I university in the Southcentral
United States. A total of 40 female college students, who either participate in varsity
intercollegiate athletics (n = 20, 50%) or voluntarily engage in habitual exercise (n = 20,
50%), participated in this study. Of the varsity athletes, there were 9 (22.5%) soccer
players, 5 (12.5%) track and field athletes, 2 (5%) track and field and cross country
runners, 2 (5%) cheerleaders, 1 (2.5%) tennis player, and 1 (2.5%) volleyball player.
Length of participation in the aforementioned sports ranged from 1 to 18 years (M =
11.45, SD = 4.883). Participants’ ages ranged from 18 to 31 years (M = 20.28, SD =
2.44). Participants’ Body Mass Index (BMI) ranged from 18.70 to 33.90 kg/m2 (M =
23.02, SD = 3.05). According to established BMI classification standards, the BMIs of all
participants fell within the healthy (18-24 kg/m2), overweight (25-29 kg/m2), or obese
(30-39 kg/m2) ranges. Participants’ body fat percentages ranged from 17.30% to 37.10%
(M = 22.82, SD = 4.51).
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Of the participants, 33 (82.5%) were white, non-Hispanic, 3 (7.5%) were African
American; 2 (5%) were Asian American, and 2 (5%) were white, Hispanic. There were
14 (35%) first-year college students, 6 (15%) second-year college students, 7 (17.5%)
third-year college students, 10 (25%) fourth-year college students, and 3 (7.5%) fifth (or
higher)-year college students. Among the participants, there were 14 (35%) Exercise
Science majors, and three (7.5%) Biology majors; the remaining 23 (57.5%) were majors
of other fields. All participants identified as heterosexual. There were 19 (47.5%)
participants who estimated their total annual family income to be over $100,000; 7
(17.5%) who estimated between $75,000 and $99,999, 7 (17.5%) who estimated between
$50,000 and $74,999, 5 (12.5%) who estimated between $35,000-$49,999, and 1 (2.5%)
who estimated less than $20,000. There was one participant who did not answer this
question. Of the participants, 30 (75%) indicated that their socioeconomic status was
average, and 10 (25%) indicated that their socioeconomic status was above average.
Measures
The participants completed a Demographics Questionnaire to provide personal
background information. Relevant anthropometric data of the participants (i.e., height and
weight) was collected at the time of the study by the researcher. Current menstrual status
and history was self-reported by participants using a questionnaire. Athlete-specific
eating disorder attitudes and behaviors were assessed by the Female Athlete Screening
Tool (FAST). The participants’ plasma Prealbumin levels were assessed through blood
protein analyses as a measure of current nutritional status. Plasma CTx levels were
evaluated via blood protein analyses to assess the bone mineral density (BMD) of the
participants.
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Demographics. Participants were asked to report their age, race/ethnicity,
education level, field of study, sexual orientation, socioeconomic status, university sport
in which they participate, and length of time they have participated in that sport at any
level of competition. See Appendix A.
Anthropometric Data. The researcher measured participants’ heights (to the
nearest 0.25 inch) with a height rod, and their weights (to the nearest 0.1 pound) with a
digital scale. The researcher used the participants’ heights and weight measurements to
calculate Body Mass Index (BMI). A handheld bioelectrical impedance analysis device
was used to obtain participants’ body fat percentages.
Menstrual Status Questionnaire. Participants answered three questions
pertaining to their current and past menstrual cycles. A sample question of this
questionnaire includes, “Have you missed three or more consecutive menstrual cycles
within the last year?” See Appendix B for Menstrual Status Questionnaire.
Female Athlete Screening Tool (FAST; McNulty et al., 2001). Participants were
asked to complete the FAST. The FAST consists of 33 questions that assess eating
disorder attitudes and behaviors. Recognizing that athletes are particularly susceptible to
eating disorders because of actions they take to be competitive in their sport, the
questions on this measure are “athlete-specific.” An example question consists of, “If I
were to be injured, I would still exercise even if I was instructed not to do so by my
athletic trainer or physician.” Questions are rated on a four-point Likert-type scale, from
1 (Strongly Agree; Frequently) to 4 (Strongly Agree; Never). The FAST demonstrates
high internal consistency (a = .87; McNulty et al., 2001). The FAST also expresses
discriminant validity, in that it distinguishes between athletes with and without eating
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disorders, as well as between athletes with eating disorders and non-athletes with eating
disorders (McNulty et al., 2001). FAST scores are typically significantly higher among
athletes with eating disorders than athletes without eating disorders and non-athletes with
eating disorders (McNulty et al., 2001). The FAST demonstrates concurrent validity, as it
has a strong association with the total scores of the Eating Disorder Inventory-2 (EDI-2; r
= .60, p < .05) and the Eating Disorder Examination Questionnaire (EDE-Q; r = .89, p <
.001; McNulty et al., 2001). In addition, the FAST shows significant correlations with
specific subscales of the EDI-2, including drive for thinness (r = .64), body
dissatisfaction (r = .76), ineffectiveness (r = .66), interpersonal distrust (r = .63),
asceticism (r = .79), and social insecurity (r = .71; McNulty et al., 2001). See Appendix
C for the FAST.
Plasma Prealbumin and CTx Blood Assay. Approximately 10mL of venous
blood was drawn from each participant using Universal Precautions (Centers for Disease
Control and Prevention [CDC], 1996). Blood samples were taken from the cubital or
cephalic vein of each participant’s arm. See Appendix D for blood sampling protocol.
Following the collection of blood samples, the researcher performed Human
Prealbumin and CTx Enzyme-linked immunosorbent assays (ELISA), also known as
enzyme immunoassays (EIA), biochemical techniques used mainly in immunology to
detect the presence of Prealbumin and CTx, respectively, within samples. See Appendix
E for ELISA protocol (Abcam, 2017).
Participation Incentive
Participants were given $10 cash at the research site after they completed the
aforementioned procedures.
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Procedures
The study was advertised to students of the university’s women’s varsity track
and field and soccer teams, introductory Biology classes, and the Exercise Science
department. Individuals who were interested in volunteering contacted the researcher to
enroll in the study. Upon arrival to the university’s Exercise Physiology Laboratory,
participants were properly consented using an Institutional Review Board (IRB) approved
informed consent document (Appendix F). After obtaining consent, participants’ heights
and weights were measured and recorded. These measurements were used to calculate
Body Mass Index (BMI). Participants’ body fat percentages were obtained using a
handheld bioelectrical impedance analysis device.
Participants completed the Demographics Questionnaire, Menstrual Status
Questionnaire, and FAST. The questionnaires took each participant approximately 10
minutes to complete. The top corner of each packet was labeled with a different number
between 1 and 40. The researcher drew approximately 10ml of venous blood from each
participant’s arm into a tube that was labeled with a number that corresponded to the
number on the individual’s packet to maintain anonymity. Participants were given a
debriefing form (Appendix G) and $10 cash after they completed the aforementioned
protocol and before they left the lab.
Following data collection, the researcher performed Human Prealbumin and CTx
Enzyme-linked immunosorbent assays (ELISAs) to detect the abundance of Prealbumin
and CTx, respectively, within the blood samples. Protein analysis of the blood samples,
using the ELISA experimental procedure, occurred in the Exercise Biochemistry lab. The
data set was kept in password protected Excel and SPSS files on a secure drive.
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Results
Preliminary Analyses
Data was analyzed and interpreted using IBM’s SPSS 24 software. Cronbach’s
alpha of the FAST was calculated to be .91, which indicates that the instrument has
excellent internal reliability. To calculate participants’ scores on the FAST, all the items
answered were summed to create a total score, using the following point system:
Frequently = 4 points; Sometimes = 3 points; Rarely = 2 points; Never = 1 point. Reverse
scoring was used for numbers 15, 28, and 32. The mean and standard deviation of the
total FAST scores were 91.49 and 14.67, respectively. The scores ranged from 58 to 124,
and were interpreted using the following criteria: < 79 = normal; 79 to 94 points =
subclinical disordered eating; > 94 points = clinical eating disorder. Using this
categorization, 8 participants (20.5%) were in the normal eating condition, 15 (38.5%)
were in the subclinical disordered eating condition, and 16 (41%) were in the clinical
eating disorder condition.
The results of a One-Way Analysis of Variance, which examined FAST scores
based on the type of eating for a manipulation check, indicated that there were
differences among the groups, F (2, 38) = 58.90, p < .001. Follow-up Scheffe tests
indicated that all three groups differed from each other. That is, participants in the normal
eating condition (M = 71.13, SD = 6.66) scored lower on the FAST than participants in
the subclinical disordered eating condition (M = 88.27, SD = 5.09) and the participants in
the clinical eating disorder condition (M = 104.69, SD = 9.09). In addition, participants in
the sub-clinical disordered eating condition scored lower on the FAST than participants
in the clinical eating disorder condition.
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Operational definitions of the three biomarkers under investigation were
established. Insufficient caloric intake was objectively identified via abnormally low
levels of plasma Prealbumin, a reliable biomarker of malnutrition. Levels < 15.0 mg/dL
were considered subthreshold. Amenorrhea was defined by the self-reported absence of
normal menstruation for at least three consecutive months without taking birth control
medication. Low BMD was defined by abnormally elevated levels (> 570 pg/mL) of
plasma CTx, a reliable biomarker of increased bone resorption and low BMD.
Hypotheses Testing
Hypothesis one states that athletes with insufficient caloric intake, manifested by
low levels of plasma Prealbumin, will score higher on the FAST than their peers with
sufficient caloric intake. To test this hypothesis, the relationship between Prealbumin
levels and FAST scores was investigated by comparing the FAST scores of participants
with subthreshold Prealbumin levels (n = 2, M = 94.00, SD = 4.24) to those of
participants with above-threshold Prealbumin levels (n = 37, M = 86.46, SD = 14.80).
This comparison was done with an independent samples t-test. Results indicated that
there were not significant differences between FAST scores of the two groups, t (37) = .711, p = .48.
Hypothesis two states that athletes with amenorrhea will score higher on the
FAST than their peers with regular menstruation. To test this hypothesis, the relationship
between amenorrhea and FAST scores was investigated by comparing the FAST scores
of participants with amenorrhea (n = 3, M = 81.33, SD = 7.64) to those of participants
with normal menstruation (n = 15, M = 89.07, SD = 15.98). This comparison was done
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with an independent samples t-test. Results indicated that there were not significant
differences between FAST scores of the two groups, t (16) = .805, p = .43.
Hypothesis three states that athletes with low BMD, manifested by high levels of
plasma CTx, will score higher on the FAST than their peers with normal BMD. To test
this hypothesis, the relationship between plasma CTx levels and FAST scores were
investigated by comparing the FAST scores of participants with increased CTx levels (n
= 9, M = 86.00, SD = 15.36) to those of participants with normal CTx levels (n = 30, M =
87.10, SD = 14.53). This comparison was done with an independent samples t-test.
Results indicated that there were not significant differences between FAST scores of the
two groups, t (37) = .197, p = .85.
Exploratory Analyses
After testing the hypotheses, additional statistical analyses were performed to
further investigate the data. Pearson correlations were used to determine if there were
relationships between participants’ total FAST scores and the presence of each of the
three biomarkers. Results of the Pearson correlations indicated that there were not
significant correlations between total FAST scores and Prealbumin levels (r[39] = .11, p
= .52), amenorrhea (r[18] = -.20, p = .43), or CTx levels (r[39] = -.06, p = .72).
Pearson correlations were also used to investigate whether relationships existed
between participants’ total FAST scores and their anthropometric measurements. Results
of the Pearson correlations indicated that there were not significant correlations between
total FAST scores and BMI (r[39] = -.26, p = .12) or body fat percentage (r[39] = -.18, p
= .26).
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Additionally, differences in biomarker presentation between the two levels of
athletic competition (i.e., varsity versus recreational) were investigated. Plasma
Prealbumin levels of varsity athletes (n = 20, M = 43.10, SD = 19.32) were compared to
those of recreational athletes (n = 20, M = 33.76, SD = 14.49), as shown in Figure 1. This
comparison was analyzed with an independent samples t-test. Results indicated that there
were not significant differences between plasma Prealbumin levels of the two groups, t
(38) = -1.730, p = .09. Plasma CTx levels of varsity athletes (n = 20, M = 505.77, SD =
121.16) were compared to those of recreational athletes (n = 20, M = 534.29, SD =
182.69), as shown in Figure 2. This comparison was analyzed with an independent
samples t-test. Results indicated that there were not significant differences between
plasma CTx levels of the two groups, t (38) = .582, p = .564.

Figure 1: Prealbumin levels of varsity versus recreational athletes
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Figure 2: CTx levels of varsity versus recreational athletes
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Discussion
Previous literature demonstrates that the athletic females are at an increased risk
of developing unhealthy eating and exercise attitudes and behaviors compared to the
general population. This information, coupled with knowledge of the negative health
consequences that often result from disordered eating such as malnutrition, amenorrhea,
and low BMD (the three biomarkers of FAT), makes this area of research critical to
restoring, maintaining, and improving the health of current and future female athletes.
Some barriers to adequately addressing these issues in the past have included lack of
instruments that screen for pathological eating while also accounting for the unique
characteristics and lifestyles of athletes, as well as the cost and time constraints that
prevent thorough physical examinations to identify the biomarkers of disordered eating.
The purpose of the present study was to investigate whether scores on the FAST, a valid
measure that was developed specifically for the population under study, are indicative of
the presence of the biomarkers that constitute FAT (McNulty et al., 2001). If so, the
FAST could be used as a preliminary diagnostic tool that does not require substantial
temporal or monetary investments. Such findings would have significant implications
because early diagnosis and immediate intervention are crucial to athletes’ recovery from
FAT and maintenance of their athletic performance and long-term health (IOC, 2005).
The first hypothesis states that athletes with insufficient caloric intake, manifested
by low levels of plasma Prealbumin, will score higher on the FAST than their peers with
sufficient caloric intake. The second hypothesis states that athletes with amenorrhea will
score higher on the FAST than their peers with regular menstruation. The third
hypothesis states that athletes with low BMD will score higher on the FAST than their
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peers with normal BMD. The three hypotheses were not supported by the results of this
study. The results revealed that there were not significant differences between the total
FAST scores of participants in each of the groups for any of the three biomarkers (i.e.,
low versus normal Prealbumin levels; amenorrhea versus normal menstruation; high
versus normal CTx levels). The results of this study indicate that there was not a
significant correlation between the participants’ total FAST scores and the presence of
the three biomarkers. This suggests that the FAST is not a valid indicator of the physical
components of FAT. Further, there was no relationship found between total FAST scores
and body mass and composition.
The current results were unexpected, based on past literature about the factors that
contribute to and/or maintain FAT, as well as the content of the FAST (Kransdorf et al.,
2013; McNulty et al., 2001; Thompson, 2007). Certain behaviors (e.g., food restriction,
unhealthy compensatory behaviors, excessive exercise) and attitudes (e.g., belief that low
body weight leads to athletic success, perfectionism, and desire to obtain the ideal
“athlete” body) are endorsed by individuals with FAT (Kransdorf et al., 2013; Thompson,
2007). Since these same behaviors and attitudes are included in the contents of the
questions on the FAST, it was expected that individuals who endorsed those items, and
had a corresponding high total FAST score, would also exhibit the physical symptoms of
FAT. It is possible that some individuals in the present study have recently adopted the
problematic attitudes and behaviors that they endorsed on the FAST; in this scenario,
their bodies may not yet reflect the three biomarkers, because physical deterioration can
be delayed in some individuals.
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Despite the aforementioned discrepancies, some of the data obtained through this
study aligns with, and further strengthens, findings from previous literature. For example,
it has been suggested that athletic females constitute a unique population that is at a high
risk of developing disordered eating habits due to their unique characteristics (IOC, 2005;
Thompson, 2007). The present study implies similar conclusions, since an overwhelming
majority of the sample (79.5%) received total FAST scores that fell in the subclinical
disordered eating or clinical eating disorder ranges. This suggests that women involved in
competitive and/or recreational sports are at a higher risk of developing disordered eating
habits or eating disorders than the general population. Additionally, results of this
research confirmed that the FAST has excellent internal consistency, and that it is a
measure that is appropriate for use among its intended population.
The results of this research further contribute to the existing body of knowledge
regarding the development of an effective screening protocol for FAT. Based on the
findings from the current study, the null hypothesis was accepted: the FAST does not
appear to be a valid stand-alone diagnostic measure for showing the physiological
characteristics of FAT. This suggests that the FAST should not be used in lieu of physical
examinations to diagnose FAT. If this study’s results had been significant, there could
have been noteworthy implications for female athletes, especially those involved in
institutions such as collegiate athletics, where screening procedures and pre-participation
exams are largely ignored (Barrack et al., 2013).
Some limitations of the current study were identified. The sample size was
relatively small, and the presence of the three biomarkers was extremely limited among
the sample, which is something that could not have been predicted a priori. More
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specifically, only two participants had low Prealbumin levels, three had amenorrhea, and
nine had elevated CTx levels. Too few participants met criteria for the diagnostic groups,
which limited the statistical power. Additionally, in the examination of amenorrhea, data
from 22 participants had to be discarded because they reported taking birth control
medication to regulate their menstrual cycle. Birth control negates the possibility of
amenorrhea; therefore, it is possible that some of these excluded individuals would have
met criteria for amenorrhea without the interference of birth control. Furthermore, plasma
levels of Prealbumin and CTx can fluctuate throughout the day, and may be affected by
exercise. If some of the participants exercised immediately before completing the study,
the protein levels in their blood sample may have slightly differed from their normal
values. Without these limitations, it is possible that the study would have yielded
different results.
Future researchers of this topic may consider the following suggestions to
counteract such limitations. A larger sample size should be used to increase the chances
of including a greater number of individuals with low Prealbumin levels, amenorrhea,
and elevated CTx levels. Future studies may consider targeting a more specific sample of
female athletes, who may be more susceptible to developing FAT, such as those who
participate in thin-build, aesthetic, or endurance sports (Barrack et al., 2013; Thompson,
2007).
To address the amenorrhea dilemma, researchers could make taking birth control
medication a participation exclusion criterion; alternatively, they could modify the
Menstrual Status Questionnaire to include additional questions, such as purpose of taking
birth control and/or menstrual history prior to taking birth control. Lastly, other methods
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could be used to examine biological markers of malnutrition and BMD to account for
potential discrepancies in blood protein values. If it is feasible to acquire the resources, a
dual-energy X-ray absorptiometry (DXA) machine could be used to perform a more
precise assessment of athletes’ BMD. Future research may also consider examining other
athlete-specific eating disorder screening tools to see if those scores are related to the
manifestation of the three components of FAT.
In conclusion, the results of this study demonstrated that there were not
significant differences between total FAST scores of participants in each of the groups
for any of the three biomarkers (i.e., low versus normal Prealbumin levels; amenorrhea
versus normal menstruation; high versus normal CTx levels). Since there was not a
significant correlation between the presence of the biomarkers of FAT and total FAST
scores, additional research should be conducted before the FAST is used as an FAT
diagnostic tool in place of physical examinations. Future research should focus on
creating new measures that are capable of simultaneously identifying disordered eating
attitudes and behaviors and the presence of FAT. If this can be accomplished, it would be
possible to implement a quick, inexpensive FAT screening protocol, diagnose the
condition more readily, and provide immediate intervention to those in need. Such a
system could prevent long-term negative health consequences and improve the overall
future health of female athletes.
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Appendix A: Demographics
1. Age:_______________
2. Race/Ethnicity:
a. African American
b. Asian American
c. White, non-Hispanic
d. White, Hispanic
e. Middle Eastern
f. Other:_______________
3. Current Academic Status:
a. First-year college student
b. Second-year college student
c. Third-year college student
d. Fourth-year college student
e. Fifth (or higher)-year college student
4. College Academic Major:_______________
5. Sexual Orientation:
a. Heterosexual
b. Homosexual
c. Bisexual
d. Other:_______________
6. Estimate your family’s combined yearly total income:
a. Less than $20,000
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b. $20,000 - $34,999
c. $35,000 - $49,999
d. $50,000 - $74,999
e. $75,000 - $99,999
f. Over $100,000
7. How would you describe your current socioeconomic status?
a. Above average
b. Average
c. Below average
8. Western Kentucky University sport in which you participate:_______________
9. Years of participation in the abovementioned sport (at any competition
level):______________
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Appendix B: Menstrual Status Questionnaire:
1. At what age did you have your first menstrual period?
2. Have you missed three or more consecutive menstrual cycles within the last year?
3. Do you (or have you previously) taken birth control to regulate your menstrual cycles?
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Appendix C: Female Athlete Screening Tool

35

Appendix D: Blood Sampling Protocol
1. Wrap a tourniquet around the patient's upper arm to stop blood flow.
2. Sterilize the puncture site with alcohol
3. Insert the needle into the vein with the bevel up
4. Attach the appropriate test tube to the needle. Allow the blood to fill the test tube.
5. Remove the tourniquet to restore blood flow
6. Place a gauze pad over the site while withdrawing the needle
7. Apply firm pressure to the site until bleeding has stopped.
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Appendix E: ELISA Protocol
Coating with capture antibody
1. Coat the wells of a PVC microtiter plate with the capture antibody at 1–10 µg/mL
concentration in carbonate/bicarbonate buffer (pH 9.6).
Unpurified antibodies (eg ascites fluid or antiserum) may require increased
concentration of the sample protein (try 10 µg/mL) to compensate for the lower
concentration of specific antibody.
2. Cover the plate with adhesive plastic and incubate overnight at 4°C.
3. Remove the coating solution and wash the plate twice by filling the wells with 200 µL
PBS. The solutions or washes are removed by flicking the plate over a sink. The
remaining drops are removed by patting the plate on a paper towel.
Blocking and adding samples
1. Block the remaining protein-binding sites in the coated wells by adding 200 µL
blocking buffer (5% non-fat dry milk/PBS) per well.
2. Cover the plate with adhesive plastic and incubate for at least 1–2 h at room
temperature or overnight at 4°C.
3. Wash the plate twice with 200 µL PBS.
4. Add 100 µL of diluted samples to each well. Always compare signal of unknown
samples against those of a standard curve. Run standards (duplicates or triplicates) and
blank with each plate. Incubate for 90 min at 37°C.
Ensure concentration of standards spans the most dynamic detection range of
antibody binding. You may need to optimize the concentration range to obtain a
suitable standard curve. Always run samples and standards in duplicate or triplicate.
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5. Remove samples and wash the plate twice with 200 µL PBS.
Incubation with detection and secondary antibody
1. Add 100 µL of diluted detection antibody to each well.
Check that the detection antibody recognizes a different epitope on the target protein
to the capture antibody. This prevents interference with antibody binding. Use a tested
matched pair whenever possible.
2. Cover the plate with adhesive plastic and incubate for 2 h at room temperature.
3. Wash the plate four times with PBS.
4. Add 100 µL of conjugated secondary antibody, diluted in blocking buffer immediately
before use.
5. Cover the plate with adhesive plastic and incubate for 1–2 h at room temperature.
6. Wash the plate four times with PBS.
Detection
1. Dispense 100 µL of the substrate solution per well with a multichannel pipette.
2. Add 100 µL of stop solution (either Horse radish peroxidase [HRP] or alkaline
phosphatase [ALP]) to the wells.
3. Read the absorbance of each well with a plate reader.
Data Analysis
1. With concentration (log scale) on the X-axis and Absorbance (linear) on the Y-axis,
create a standard curve using the data obtained from the serial dilutions.
2. Interpolate the concentration of the sample from the curve.
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Appendix F: Informed Consent Document
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Appendix G: Debriefing
Thank you for participating in this study. All of the information received from this
survey will be kept confidential. The purpose of this project is to evaluate whether the
FAST is a valid indicator of the three symptoms of Female Athlete Triad, and determine
if it can be reliably used for screening of this condition among female collegiate athletes.
This study could benefit female collegiate athletes by providing university athletic
departments with a cost and time-effective screening method. This could reduce the
development and subsequent negative health consequences that occur as a result of this
condition.
Female Athlete Triad is a serious condition effectively treated through a
multidisciplinary team of health care professionals, i.e., medical doctor, psychologist, and
nutritionist; and the support of family, teammates, and coaches. If treated in a timely
manner, most athletes can successfully restore their health and establish new healthy
eating and exercise habits. With restored energy and strength, many athletes experience
improved performance.
The occurrence of Female Athlete Triad is not uncommon, especially among
competitive athletes at the high school and collegiate level. If you believe that Female
Athlete Triad currently affects you or someone you know, please find more information
at the resources provided below and seek medical attention as soon as possible.
If you would like more information about this study or have additional questions,
please contact Lindsey Hinken (lindsey.hinken301@topper.wku.edu) or her advisor Dr.
Rick Grieve (rick.grieve@wku.edu).

More information can be found at the following link:
https://www.acsm.org/docs/brochures/the-female-athlete-triad.pdf
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